NCT02940496
- Conditions
- Adenocarcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, +28 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Refractory Liver Carcinoma
Explore clinical trials studying Refractory Liver Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Refractory Liver Carcinoma trial results
Active, Not Recruiting
IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer
NCT03655002
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Texas Oncology at Baylor Charles A Sammons Cancer Center Dallas, Texas, United States